Susquehanna Portfolio Strategies, LLC
Position in MRK — Merck & Co., Inc.
CIK 1996449
Bala Cynwyd, PA
Position in MRK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$12,522,839
-$82,714,964 QoQ
Shares Held
97,454
-87.7% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#662
of 3,769 holders
Holding Since
Dec 2023
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Susquehanna Portfolio Strategies, LLC holds $224,464,092 across 7 Drug Manufacturers - General names. MRK ranks #5 (5.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
332,871 | $83,763,658 | |
| 2 | AMGN |
Amgen Inc
|
151,362 | $54,811,207 | |
| 3 | LLY |
ELI LILLY & Co
|
29,264 | $35,100,122 | |
| 4 | BIIB |
Biogen Inc.
|
98,801 | $21,346,944 | |
| 5 | MRK |
Merck & Co., Inc.
This page
|
97,454 | $12,522,839 | |
| 6 | PFE |
Pfizer Inc
|
485,837 | $11,698,954 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
41,320 | $5,220,368 |
All Filings in MRK
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,522,839 | 97,454 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $95,237,803 | 791,735 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $83,338,026 | 791,735 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $66,450,318 | 791,735 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $63,387,607 | 800,753 | Shares | Sole | 2025-08-14 | |
| 2024-09-30 | $38,244,963 | 336,782 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $41,693,611 | 336,782 | Shares | Defined | 2024-08-15 | |
| 2024-03-31 | $49,360,119 | 374,082 | Shares | Defined | 2024-05-07 | |
| 2023-12-31 | $40,782,419 | 374,082 | Shares | Defined | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||